Is There an Ischemic Threshold Beyond Which Percutaneous Coronary Intervention Is Beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial?

American Journal of Cardiology

Volumn 100, Issue 9, 2007, Pages 1495-

  Bangalore, Sripal ^a   Messerli, Franz H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG SCREENING; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGING; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; STENOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; TREATMENT OUTCOME;

EID: 35348818085     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.05.045     Document Type: Letter

References (2)

1. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
2. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., and Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 (2003) 2900-2907